All Hematologic OI Articles

Hear from a multiple myeloma treatment team about their experience implementing a bispecific antibody therapy in the community setting.

Key findings from three case studies highlight the challenges and triumphs in treating chronic lymphocytic leukemia with oral oncolytics.

Tennessee Oncology is a physician-led private oncology practice based in Nashville, with 32 clinic locations across the state and one in northern Georgia- offering medical and radiation oncology, imaging, and lab services.

The purpose of this study was to assess patient, disease, and medication-related factors that affect the rate of unplanned readmissions before next chemotherapy cycle or within 30 days since last chemotherapy admission in patients with hematologic malignancies.

In 2020 ACCC offered quality improvement programs designed to optimize care for patients with multiple myeloma.

In 2020 ACCC offered quality improvement programs designed to optimize care for patients with acute lymphocytic leukemia.

City of Hope’s bone marrow transplant program has performed more than 16,000 transplants and continues to be one of the largest and most successful programs in the nation.

Eyes on Cancer provides a 20-minute online educational video about the different types of skin cancer with photos of each kind, a melanoma lesion photo reference card within the video, and an online 35-question post-test. When finished, hairdressers can print and display a certificate of completion in their salon.

Prior to learning that I had multiple myeloma, I was planning to participate in a 200-mile bike race from Logan, Utah, to Jackson Hole, Wyoming, (the LOTOJA race). But learning that I had cancer changed everything. Instead of cycling, I would be fighting for my life.

Though the incidence of AIDS-defining cancers has decreased with the use of antiretroviral therapy, numerous studies suggest that non-AIDS-defining cancers (cancers not previously associated with HIV and AIDS) appear to be increasing in incidence.

ASCO 2018 offered a wealth of new data that will continue to transform clinical practice and cancer program development. Most important, implementation of the scientifi c advances we learned at ASCO 2018 will improve the length and quality of life of our cancer patients.

Multi-site, integrated health care systems have a unique opportunity to provide patient-centered care on a large scale. Discover how Aurora Cancer Care improved their quality of care through subspecialization, consistent care processes, and more.